Projects / Research / Grants

Hey there mate!


Your lost treasure is not found here…

Check again your spelling and rewrite the content you are seeking for in the search field.

Grants

Awards

WARREN Y. SOPER KIDNEY CANCER RESEARCH GRANT 2025

Applications Open: July 21th, 2025

Application Submission Deadline: September 26th, 2025

Official winner (s) announcement by November 2025

Background

The Kidney Cancer Research Network of Canada (KCRNC) has entered into a collaboration with Kidney Cancer Canada (KCC) to provide financial support for research within the Canadian kidney cancer research community. Kidney Cancer Canada has received funding from the Warren Y. Soper Trust to fund research projects in 2025.

Objectives and Scope

The objective of the KCRNC Research Grant Program is to support peer-reviewed research that promotes excellence in kidney cancer research. This grant competition is funded by Warren Y. Soper Charitable Trust, via Kidney Cancer Canada.

Grants will be awarded to the successful applicant(s) (or applicant’s institution on behalf of the applicant, if applicable). It is anticipated that one grant(s) will be awarded, for up to $100,000 for 1 year (with possibility of extension). Funding will be provided over a 12-month performance period. Amount per grant to be funded is dependent on the requests and the quality of the applications.

Eligibility

The KCRNC Project Manager (Maria Komisarenko, Maria.Komisarenko@uhn.ca )will receive and process the submitted proposals. Proposals will be awarded grants based on the following:

  • This research award is designated to support a faculty member or trainee in Canada.
  • Agrees to provide a progress report, including publication plan, to KCRNC for dissemination of study results.
  • Agrees to acknowledge Kidney Cancer Research Network of Canada, The Warren Y. Soper Charitable Trust, Kidney Cancer Canada in publication for funding.

Eligible Research Proposals

The research proposals must be in kidney cancer research conducted in Canada. Basic science, clinical research projects, and projects identifying unmet supportive care needs and/or improving shared decision-making will be accepted. Preference will be given to the following:

  • Junior investigators (less than 5 years experience) or trainees
  • New/pilot projects that have not been previously funded (this award is not for those looking for fund  extensions to a currently funded project.
  • Projects that are bringing novel advancements to current research

The study must be completed within 12 months of receipt of funding; extensions will be considered. The proposed application should be a ‘stand alone’ project.

Non-eligible Research Proposals

The following types of proposals will not be eligible:

  • Proposals for projects that are adequately funded from another source, including government or industry sponsors, will not be eligible
  • Proposals for pharmaceutical product development (including studies on non-approved indications for

   drugs) and/or product comparison, or product promotion will not be considered.

Review Criteria

The KCRNC-KCC Grant proposals will be reviewed and approved by appointed KCRNC, and Kidney Cancer Canada grant review members. Research proposals will be evaluated based on the following criteria:

  1. Scientific Merit:
    • Rationale
    • Originality
  2. Methodology
  3. Impact
    • Contribution to advancement of scientific knowledge in relevant therapeutic field
    • Clinical relevance or potential clinical value and applicability
  4. Feasibility
    • Feasibility of study design, methodology, analysis
    • Adequate power and sample size
    • Proposed timelines.
  5. Budget
  6. Qualifications of applicant and supporting team
  7. Institutional Support and Resources

RATING SCALE: Score

Rating Scale Description
Priority for Funding
4.8 – 5.0

Outstanding proposal with original and innovative aims. Research proposed is at the forefront internationally and led by outstanding team. The research addresses extremely important questions, challenges existing paradigms and will substantially improve our knowledge of renal cell carcinoma.

Highest
4.5 – 4.7
Exceptional quality research that is highly significant, innovative, and internationally competitive. Driven by an exceptional team, the research addresses crucial questions and will have a major impact on our understanding of renal cell carcinoma.
High
4.2 – 4.4
Excellent quality research that addresses very important and original questions. The research will have a significant impact on the relevant scientific field.
High
3.8 – 4.1
High quality research that can be classified as very good, bordering excellent. The results will likely contribute considerably to knowledge in the scientific field.
Medium
3.4 – 3.7

Very good research that has the potential to improve our current knowledge of kidney cancer. Some minor weaknesses in the proposal, while diminishing enthusiasm, can easily be corrected.

Medium
3.0 – 3.3
Good quality research that may yield important results. There are concerns with the proposal that can be addressed during the term of the grant.
Low
Below 3.0
Research proposal has potential. However, there are weaknesses that need to be reconciled for it to be successful. The proposal is in need of further development before being competitive.
Low